Company Filing History:
5 out of 451 
1 out of 832,880 Years Active: 1999-2002
Title: Marylou G Gibson: Innovator in Cytokine Research
Introduction
Marylou G Gibson is a prominent inventor based in Carlsbad, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of cytokine research. With a total of 6 patents, her work has had a profound impact on the development of therapeutic applications.
Latest Patents
Among her latest patents is the invention related to DNA encoding CD40 ligand, a cytokine that binds CD40. This patent discloses a polypeptide (CD40-L) along with DNA sequences, vectors, and transformed host cells that are useful in providing CD40-L polypeptides. More specifically, it provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor. Another significant patent involves the use of CD40 ligand to stimulate hybridoma cells. This invention outlines methods for increasing monoclonal antibody production by administering a CD40 ligand polypeptide that stimulates B cell proliferation.
Career Highlights
Marylou has worked with notable companies in the biotechnology sector, including Immunex Corporation. Her innovative research has paved the way for advancements in immunology and therapeutic treatments.
Collaborations
Throughout her career, Marylou has collaborated with esteemed colleagues such as Richard Jeffrey Armitage and William Christian Fanslow, III. These collaborations have further enhanced her contributions to the field.
Conclusion
Marylou G Gibson's work in cytokine research and her numerous patents highlight her role as a leading innovator in biotechnology. Her contributions continue to influence the development of new therapeutic strategies.